These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 28183996)

  • 1. Antibiotic tolerance facilitates the evolution of resistance.
    Levin-Reisman I; Ronin I; Gefen O; Braniss I; Shoresh N; Balaban NQ
    Science; 2017 Feb; 355(6327):826-830. PubMed ID: 28183996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration and suppression of resistance development by antibiotic combinations.
    Suzuki S; Horinouchi T; Furusawa C
    BMC Genomics; 2017 Apr; 18(1):328. PubMed ID: 28446153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral sensitivity of antibiotic-resistant microbes.
    Pál C; Papp B; Lázár V
    Trends Microbiol; 2015 Jul; 23(7):401-7. PubMed ID: 25818802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations.
    Fridman O; Goldberg A; Ronin I; Shoresh N; Balaban NQ
    Nature; 2014 Sep; 513(7518):418-21. PubMed ID: 25043002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens.
    Igler C; Rolff J; Regoes R
    Elife; 2021 May; 10():. PubMed ID: 34001313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis between antibiotic tolerance, persistence, and resistance mutations.
    Levin-Reisman I; Brauner A; Ronin I; Balaban NQ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14734-14739. PubMed ID: 31262806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme.
    Salverda MLM; Koomen J; Koopmanschap B; Zwart MP; de Visser JAGM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12773-12778. PubMed ID: 29133391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic induced bacterial lysis provides a reservoir of persisters.
    Podlesek Z; Butala M; Šakanović A; Žgur-Bertok D
    Antonie Van Leeuwenhoek; 2016 Apr; 109(4):523-8. PubMed ID: 26821377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics.
    Tyerman JG; Ponciano JM; Joyce P; Forney LJ; Harmon LJ
    BMC Evol Biol; 2013 Jan; 13():22. PubMed ID: 23356665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of antibiotic resistance by mutation.
    Woodford N; Ellington MJ
    Clin Microbiol Infect; 2007 Jan; 13(1):5-18. PubMed ID: 17184282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.
    Rossolini GM; Docquier JD
    Future Microbiol; 2006 Oct; 1(3):295-308. PubMed ID: 17661642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics.
    Karami N; Martner A; Enne VI; Swerkersson S; Adlerberth I; Wold AE
    J Antimicrob Chemother; 2007 Nov; 60(5):1142-5. PubMed ID: 17768176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Darwinian evolution can follow only very few mutational paths to fitter proteins.
    Weinreich DM; Delaney NF; Depristo MA; Hartl DL
    Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
    Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.
    Wiuff C; Zappala RM; Regoes RR; Garner KN; Baquero F; Levin BR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1483-94. PubMed ID: 15793130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.